Reversal of Remimazolam by a Single Dose of Flumazenil

Status Completed

Clinical Trial Summary

Remimazolam, a brand-new sedative which has benzodiazepine property. It is an ultra-short acting sedative and regarded as a proper drug for procedural sedation.

Clinical Trial Description

As ambulatory surgery has been increased last two decades, 'Enhanced Recovery After Surgery (ERAS)' also has become an important issue in clinical fields. It is very critical that managing postoperative pain, postoperative nausea and vomiting (PONV) and rapid recovery with less complication or side effect to anesthesiologists. Even though remimazolam considered as an ultra-short acting sedative, it shows a relatively longer recovery time than propofol. Fortunately, remimazolam has its own antidote, called 'flimazenil'. With flumazenil, the time to recovery of consciousness dramatically reduces. Common side effects of flumazenil include headache, dizziness, nausea, vomiting, flushing, sweating and injection pain. In this trial we would like to demonstrate that routine single dose of flumazenil could be administered as an antidote of remimazolam without complications or side effects in gynecologic ambulatory surgery. ;

Study Design

Related Conditions & MeSH terms

Ambulatory Surgery
Postoperative Nausea
Postoperative Nausea and Vomiting
Remimazolam

Clinical Trial Details

NCT number	NCT05382806
Study type	Interventional
Source	Konkuk University Medical Center
Contact
Status	Completed
Phase	N/A
Start date	August 2, 2022
Completion date	May 13, 2023

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03639012` - Outcomes of Carbohydrate Loading Paediatric Patients Preoperatively for Tonsillectomy and Adenoidectomy	N/A
Not yet recruiting	`NCT01389570` - Postoperative Nausea/Vomiting and Acupressure	Phase 2
Completed	`NCT00830089` - Trial of a Transversus Abdominis Plane (TAP) Block in Laparoscopic Colorectal Surgery	N/A
Terminated	`NCT05112575` - Evaluation of Patient Stress Level Caused by Radiological Investigations in Early Postoperative Phase After Craniotomy
Completed	`NCT04759079` - The Effects of Acupuncture Against Postoperative Nausea and Vomit After Laparoscopic Cholecystectomy	N/A
Active, not recruiting	`NCT03712891` - Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU	N/A
Completed	`NCT01834898` - Safety and Tolerability of Controlled-release Oxycodone on Postoperative Pain in Oncologic Head and Neck Surgery	N/A
Completed	`NCT03631004` - Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients	Phase 2/Phase 3
Completed	`NCT05618236` - Sugammadex and Neostigmine in Pediatric Patients
Not yet recruiting	`NCT05632224` - Postoperative Nausea and Vomiting in Laparoscopic Abdominal Surgery	Phase 4
Completed	`NCT01020903` - Aprepitant for Post-operative Nausea	N/A
Completed	`NCT00793663` - Depth of Hypnosis and Postoperative Nausea and Vomiting During Xenon Anaesthesia	Phase 4
Completed	`NCT03503292` - Pharmacogenomics and Post-Operative Nausea and Vomiting	Phase 4
Completed	`NCT05841693` - Quality of Recovery in Parturients Consumed Preoperative Carbohydrate Fluid for Elective Cesarean Delivery	Phase 4
Completed	`NCT04742660` - The Effect of Glycyrrhizin on the Occurrence of Postoperative Nausea and Vomiting	N/A
Completed	`NCT03100669` - Implementing a Postoperative MIRP (Minimally Invasive Repair of Pectus) Program Via Tele-monitoring
Terminated	`NCT02765750` - Postoperative Outcomes After Positive Intraoperative Messages	N/A
Terminated	`NCT01798316` - IV Acetaminophen for Postoperative Analgesia	Phase 4
Completed	`NCT03387956` - Intrathecal Atropine to Prevent Postoperative Nausea and Vomiting	N/A
Completed	`NCT04718727` - Olanzapine for the Prevention of Postoperative Nausea and Vomiting	Phase 1/Phase 2